Business Description
![Redhill Biopharma Ltd Redhill Biopharma Ltd logo](https://static.gurufocus.com/logos/0C00008RR1.png?14)
Redhill Biopharma Ltd
NAICS : 325412
ISIN : US7574681034
Share Class Description:
RDHL: ADRDescription
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
Financial Strength
4/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 4.75 | |||||
Equity-to-Asset | 0.09 | |||||
Debt-to-Equity | 0.57 | |||||
Debt-to-EBITDA | 0.01 | |||||
Interest Coverage | 0.21 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -9.61 | |||||
Beneish M-Score | 1.26 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -75.7 | |||||
3-Year EPS without NRI Growth Rate | 72.1 | |||||
3-Year FCF Growth Rate | 63.3 | |||||
3-Year Book Growth Rate | -80.6 |
Momentum Rank
7/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 56.56 | |||||
9-Day RSI | 52.49 | |||||
14-Day RSI | 49.56 | |||||
6-1 Month Momentum % | -41.36 | |||||
12-1 Month Momentum % | -70.7 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 0.84 | |||||
Quick Ratio | 0.61 | |||||
Cash Ratio | 0.29 | |||||
Days Inventory | 116.79 | |||||
Days Sales Outstanding | 119.65 | |||||
Days Payable | 66.81 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -173.7 | |||||
Shareholder Yield % | 126.04 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 42.74 | |||||
Operating Margin % | 21.31 | |||||
Net Margin % | 32.37 | |||||
FCF Margin % | -73.43 | |||||
ROE % | Neg. Equity | |||||
ROA % | 16.78 | |||||
ROIC % | 8.96 | |||||
ROC (Joel Greenblatt) % | 1095.96 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Price-to-Owner-Earnings | 1.04 | |||||
PS Ratio | 0.02 | |||||
PB Ratio | 3.61 | |||||
EV-to-EBIT | 0.16 | |||||
EV-to-EBITDA | 0.07 | |||||
EV-to-Forward-EBITDA | -3.75 | |||||
EV-to-Revenue | 0.22 | |||||
EV-to-Forward-Revenue | 1.37 | |||||
EV-to-FCF | -0.29 | |||||
Earnings Yield (Greenblatt) % | 625 | |||||
FCF Yield % | -207.61 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:RDHL
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Redhill Biopharma Ltd Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil $) | 35.745 | ||
EPS (TTM) ($) | -3.807 | ||
Beta | 5.43 | ||
Volatility % | 374.18 | ||
14-Day RSI | 49.56 | ||
14-Day ATR ($) | 0.022427 | ||
20-Day SMA ($) | 0.37122 | ||
12-1 Month Momentum % | -70.7 | ||
52-Week Range ($) | 0.257 - 3.28 | ||
Shares Outstanding (Mil) | 31.87 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Redhill Biopharma Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Redhill Biopharma Ltd Stock Events
Event | Date | Price($) | ||
---|---|---|---|---|
No Event Data |
Redhill Biopharma Ltd Frequently Asked Questions
What is Redhill Biopharma Ltd(RDHL)'s stock price today?
The current price of RDHL is $0.40. The 52 week high of RDHL is $3.28 and 52 week low is $0.26.
When is next earnings date of Redhill Biopharma Ltd(RDHL)?
The next earnings date of Redhill Biopharma Ltd(RDHL) is 2024-08-05 Est..
Does Redhill Biopharma Ltd(RDHL) pay dividends? If so, how much?
Redhill Biopharma Ltd(RDHL) does not pay dividend.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |